BISMUTH VS NON-BISMUTH (CONCOMITANT) QUADRUPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引:0
|
作者
Cominardi, A. [1 ]
Marasco, G. [1 ]
Russo, T. [2 ]
Cirota, G. G. [1 ]
Galloro, G. [3 ]
Romano, M. [4 ]
Bazzoli, F. [1 ]
Zagari, R. M. [1 ]
机构
[1] St Orsola Marcello Malpighi Hosp, Bologna, Italy
[2] Univ Campania Luigi Vanvitelli, Naples, Italy
[3] Univ Naples Federico II, Naples, Italy
[4] Kings Coll London, London, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OC.03.5
引用
收藏
页码:S13 / S13
页数:1
相关论文
共 50 条
  • [1] Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori
    Pereira, F.
    Azevedo, R.
    Linhares, M.
    Ramos, D.
    Pinto, J.
    Caldeira, A.
    Tristan, J.
    Pereira, E.
    Sousa, R.
    Banhudo, A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [2] Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication:A randomized study in Japan
    Ayako Yanai
    Kei Sakamoto
    Masao Akanuma
    Keiji Ogura
    Shin Maeda
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (01) : 1 - 6
  • [4] Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
    Gisbert, Javier P.
    Calvet, Xavier
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 23 - 34
  • [5] Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zagari, Rocco Maurizio
    Dajti, Elton
    Cominardi, Anna
    Frazzoni, Leonardo
    Fuccio, Lorenzo
    Eusebi, Leonardo Henry
    Vestito, Amanda
    Lisotti, Andrea
    Galloro, Giuseppe
    Romano, Marco
    Bazzoli, Franco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [6] NON-BISMUTH QUADRUPLE (CONCOMITANT) THERAPY FOR ERADICATION OF HELICOBATER PYLORI: A SYSTEMATIC REVIEW
    Gisbert, J. P.
    Calvet, X.
    HELICOBACTER, 2011, 16 : 131 - 131
  • [7] OPTIMUM DURATION OF NON BISMUTH ( CONCOMITANT) QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Cirota, G. G.
    Marasco, G.
    Russo, T.
    Cominardi, A.
    Galloro, G.
    Romano, M.
    Bazzoli, F.
    Zagari, R. M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S73 - S73
  • [8] BISMUTH QUADRUPLE THERAPY VERSUS CONCOMITANT THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: SYSTEMATIC REVIEW AND META-ANALYSIS
    Dajti, E.
    Cominardi, A.
    Frazzoni, L.
    Fuccio, L.
    Eusebi, L. H.
    Vestito, A.
    Lisotti, A.
    Galloro, G.
    Romano, M.
    Bazzoli, F.
    Zagari, R. M.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S173 - S174
  • [9] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Te-Ling Ma
    Wei-Chen Tai
    Song-Seng Loke
    Chih-Chien Yao
    Chih-Ming Liang
    Seng-Kee Chuah
    Drugs & Aging, 2023, 40 : 71 - 79
  • [10] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Ma, Te-Ling
    Tai, Wei-Chen
    Loke, Song-Seng
    Yao, Chih-Chien
    Liang, Chih-Ming
    Chuah, Seng-Kee
    DRUGS & AGING, 2023, 40 (01) : 71 - 79